Antimitotic and cytotoxic effects of theophylline in MDA-MB-231 human breast cancer cells

Breast Cancer Research and Treatment

Volumn 64, Issue 3, 2000, Pages 259-267

  Slotkin, T A ^a   Seidler, F J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase; Cell replication; Cyclic AMP; DNA synthesis; Protein synthesis; Theophylline; Xanthine derivatives

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA CONTENT; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; ADENYLATE CYCLASE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL ADHESION; CELL SURVIVAL; DNA; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MITOSIS; PHOSPHODIESTERASE INHIBITORS; THEOPHYLLINE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034527977     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026508605951     Document Type: Article

References (40)

1. 2-agonist, clenbuterol, on cultured human (CG-5) breast cancer cells
2. β-Adrenergic receptors in human breast cancer: Identification, characterization and correlation with progesterone and estradiol receptors
3. Cyclic AMP inhibits the growth of human breast cancer cells in defined medium
4. Functional coupling of neurotransmitters with second messengers during cleavage divisions: Facts and hypotheses
5. 2 adrenergic receptor
6. Biochemical aspects of cardiac muscle differentiation
7. Synergistic effects of neurotensin and b-adrenergic agonist on 3′, 5′-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC 3 cells
8. Expression of Q227L-Gas in MCF- 7 human breast cancer cells inhibits tumorigenesis
9. B-Adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells
10. 2-Adrenergic receptor mRNA is overexpressed in neoplastic human thyroid tissues
11. Evidence for functional β-adrenoceptor subtypes in CG- 5 breast cancer cells
12. 2-adrenoceptor by sustained treatment with inverse agonists but not antagonists
13. Noradrenaline inhibits the programmed cell death induce by 1,25-dihydroxyvitamin D- 3 in glioma
14. Functional Badrenergic receptors in breast cancer cells
15. A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: Hormonal control of β-adrenergic receptors and correlation with tumor growth
16. 2-Adrenergic effect on human breast cancer MCF- 7 cells
17. Growth factor and cyclic nucleotide-induced proliferation of normal and malignant mammary epithelial cells
18. A new generation of phosphodiesterase inhibitors: Multiple molecular forms of phosphodiesterase and the potential for drug selectivity
19. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences
20. Effects of dibutyryl cyclic adenosine 3′:5′-monophosphate on the growth of cultured human small-cell lung carcinoma and the specific cellular activity of l-dopa decarboxylase
21. Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation
22. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7)
23. The effect of papaverine on morphologic differentiation, proliferation and invasive potential of human prostatic cancer LNCaP cells
24. Adenosine modulates ceil proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine Al receptor subtypes in HT 29 cells
25. A cautionary note: The actions of adenosine agonists and antagonists may be reversed under certain conditions in primary cultures
26. Nitric oxide, peroxynitrite and nitroso-compounds formation by ultraviolet A (UVA) irradiated human squamous cell carcinoma: Potential role of nitric oxide in cancer prognosis
27. Acceleration of adhesion of cancer cells and neutrophils to endothelial cells in the absence of de novo protein synthesis: Possible implication for involvement of hydroxyl radicals
28. Nitric oxide and oxygen radicals in infection, inflammation, and cancer
29. A novel cancer therapy based on oxygen radicals
30. Effects of α-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase, on nucleic acids and proteins in developing rat brain: Critical perinatal periods for regional selectivity
31. Protein measurement with the folin phenol reagent
32. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat
33. Control of adenylate cyclase activity in developing rat heart and liver: Effects of prenatal exposure to terbutaline or dexamethasone
34. Hyperoxia induces the differentiated neuronal phenotype of PC 12 cells by producing reactive oxygen species
35. Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro
36. Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma
37. 3 adenosine receptor activation and its suppression by isoproterenol
38. Methylxanthines: Toxicity to humans. 1. Theophylline
39. Methylxanthines and benign proliferative epithelial disorders of the breast in women